Company intelligence / Profile preview

Taiclone

Taipei, Taipei City, Taiwan

Ownership: Private
Development stage: Other

Overview

Taiclone is a biotechnology company headquartered in Taipei, Taiwan, that provides a comprehensive range of research reagents to the global life science community. The company's product portfolio includes over 50,000 antibodies, 10,000 ELISA kits, and a wide selection of small molecule inhibitors and recombinant proteins. Taiclone serves researchers in diverse fields such as oncology, immunology, and neuroscience, offering tools designed to facilitate high-impact scientific discoveries. With a focus on quality and reliability, the company supports both academic institutions and pharmaceutical R&D departments worldwide.

Modalities: AntibodySmall moleculeRecombinant proteinELISA kit
Industry: Non-Drug Biotech

Beyond the preview

Go deeper on Taiclone.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Taiclone.

Explore the full profile